Search Contract Opportunities

Solifenacin Succinate Amendment 0002   3

ID: SPE2D220R0066 • Type: Solicitation • Match:  85%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this contract have any security clearance requirements?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: June 10, 2020, 11:03 a.m. EDT

Issue of Amendment 0002 removing references to Veterans Administration, Bureau of Prisons, and Indian Health Services. See attached revised solicitation.

Posted: June 2, 2020, 2:22 p.m. EDT
Posted: May 27, 2020, 12:39 p.m. EDT
Background
The Defense Logistics Agency (DLA), Directorate of Medical Materiel provides pharmaceutical products for the Department of Defense (DoD) through its Pharmaceutical Prime Vendor program. This solicitation aims to establish a national contract for Solifenacin Succinate, ensuring availability and consistency of product.

Work Details
The contract involves the supply of Solifenacin Succinate in various forms:
- 5MG 30 count bottles
- 5MG 90 count bottles
- 10MG 30 count bottles
- 10MG 90 count bottles.

The estimated quantities per year are as follows:
- 15,983 bottles for the 5MG 30 count
- 19,626 bottles for the 5MG 90 count
- 5,845 bottles for the 10MG 30 count
- 29,103 bottles for the 10MG 90 count.

These quantities are estimates only.

Period of Performance
The contract duration is one base year with four option years, totaling a maximum of five years.

Place of Performance
Delivery will be made to multiple Pharmaceutical Prime Vendor distribution centers.

Overview

Agency
DLA Troop Support - Medical [DoD - DLA]
Response Deadline
June 29, 2020, 3:00 p.m. EDT Past Due
Posted
May 27, 2020, 12:39 p.m. EDT (updated: June 10, 2020, 11:03 a.m. EDT)
Set Aside
None
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Not Provided
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 5/27/20 DLA Troop Support - Medical issued Solicitation SPE2D220R0066 for Solifenacin Succinate Amendment 0002 due 6/29/20. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Denise Taubman   Profile
Email
denise.taubman@dla.mil
Phone
(215) 737-6877

Secondary Contact

Name
Jason Wray   Profile
Email
jason.wray@dla.mil
Phone
(215) 737-0614

Documents

Posted documents for Solicitation SPE2D220R0066

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation SPE2D220R0066

Award Notifications

Agency published notification of awards for Solicitation SPE2D220R0066

IDV Awards

Indefinite delivery vehicles awarded through Solicitation SPE2D220R0066

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation SPE2D220R0066

Similar Active Opportunities

Open contract opportunities similar to Solicitation SPE2D220R0066

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2D2
Source Organization Code
500045947
Last Updated
June 29, 2025
Last Updated By
PI33_DR_IAE_51681
Archive Date
June 28, 2025